HK Stock MarketDetailed Quotes

00512 GRANDPHARMA

Watchlist
  • 4.110
  • -0.100-2.38%
Market Closed Mar 28 16:08 CST
14.59BMarket Cap7.75P/E (TTM)

About GRANDPHARMA Company

The Group is a technologically innovative international pharmaceutical enterprise. Its core business spans the three fields of pharmaceutical technology, nuclear drug anti-tumor diagnosis and treatment, cardiovascular precision interventional diagnosis and treatment technology, and biotechnology. The Group is based on the pharmaceutical and biological industries, with patients' needs as the core, scientific and technological innovation as the driving force. In response to unmet clinical needs, the Group will increase investment in global innovative products and advanced technology, enrich and improve product pipelines, consolidate and strengthen the industrial chain layout, give full play to the Group's industrial advantages and R&D capabilities, and provide more advanced and diverse treatment plans for patients around the world. Through unremitting efforts in recent years, the Group's development foundation has become more stable, the scale of operation has been consolidated, its business structure has been gradually optimized, its business methods have continued to improve, the pace of transformation and upgrading has accelerated, and its innovative layout has blossomed more. The Group's profitability continues to increase, helping R&D and innovation; its good mergers and acquisitions and integration capabilities continue to consolidate the scale of development; integrating raw materials and formulations to improve the structure of the industrial chain; and diversification of business and entities, effectively strengthening its comprehensive advantages. “Steady Growth, Strong Innovation, and Strategy Planning”, the Group will continue to focus on meeting patients' needs, follow the direction of market development, adhere to scientific and technological innovation as the driving force, adhere to the development concept of “comprehensive advantage, innovation leadership and global expansion”, and adopt the strategy of “independent R&D and global expansion of two-wheel drive, global operation layout and dual cycle business development” to form a new pattern of dual cycle joint development and mutual promotion at home and abroad. It is committed to becoming a technologically innovative international pharmaceutical enterprise respected by doctors and patients and restored to society.

Company Profile

Symbol00512
Company NameGRANDPHARMA
ISINBMG210A71016
Listing Date12/19/1995
Issue Price1.50
Shares Offered200.00M share
Founded10/18/1995
RegistrationBermuda
ChairmanWeikun Tang
SecretaryTianzhong Fu
Audit InstitutionGuowei Certified Public Accountants Co., Ltd.
Company CategoryOther
Registered OfficeClarendon House2 Church Street Hamilton HM11 Bermuda
Head Office and Principal Place of BusinessRoom 3302, Central Centre, 99 Queen's Road Central, Hong Kong
Fiscal Year Ends12-31
Employees10534
MarketHong Kong motherboard
Phone(852)2116-1968
Fax(852)2865-2739
Emailinfo@chinagrandpharm.com
Business Yuanda Pharmaceutical Group Co., Ltd. (former name: Yuanda Healthcare Holdings Limited) is a Hong Kong investment holding company mainly engaged in the manufacture and sale of pharmaceutical preparations and medical devices. The company is mainly engaged in the manufacture and sale of pharmaceutical preparations and medical devices, biotechnology products and nutritional products, premium raw materials and other products. The company's main products include anti-tumor, cardiovascular first aid preparations and high-end cardiovascular and cerebrovascular interventional medical devices, antiviral and anti-infective, respiratory and facial medicine, and bio-health products and premium raw materials.

Company Executives

  • Name
  • Position
  • Salary
  • Weikun Tang
  • Executive Director,Chairman of the Board,Remuneration Committee Member,President of Yuanda Pharmaceutical (China)
  • --
  • Lin Shi
  • Executive Director,Vice President and Chief Medical Officer of Yuanda Pharmaceutical (China)
  • --
  • Guang Yang
  • Executive Director
  • --
  • Caiyun Su
  • Nomination Committee Chairman,Independent Non-Executive Director,Remuneration Committee Chairman,Audit Committee Chairman
  • --
  • Yebi Hu
  • Remuneration Committee Member,Audit Committee Members,Nomination Committee Member,Independent Non-Executive Director
  • --
  • Geng Pei
  • Audit Committee Member,Independent Non-Executive Director
  • --
  • Chao Zhou
  • CEO,Nomination Committee Member,Executive Director
  • --
  • Xiaofeng Shi
  • Chairman of Yuanda Pharmaceutical (China)
  • --
  • Tianzhong Fu
  • Company Secretary,Authorized Representative
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
%Chg